FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310289576> ?p ?o ?g. }

• W4310289576 endingPage "11" @default.
• W4310289576 startingPage "1" @default.
• W4310289576 abstract "Background. Estrogen and progesterone receptor status can predict breast cancer patient prognosis and treatment sensitivity, but research on low ER and PR levels and expression balance remains limited. Methods. From January 2010 to October 2016, 283 ER+/PR+/HER2-breast cancer patients who met the inclusion criteria were enrolled and divided into the H group (ER > 10%, N = 261) and the L group (1% ≤ ER ≤ 10%, N = 22). Groups were further divided into the HH group (ER > 10%/PR > 20%, N = 201), the HL group (ER > 10%/ER 1% ≤ PR ≤ 20% PR, N = 60), the LH group (1% ≤ ER ≤ 10%/PR > 20%, N = 5), and the LL group (1% ≤ ER ≤ 10%/1% ≤ PR ≤ 20%, N = 17). The LH group was excluded due to its small size, leaving the clinical and prognostic characteristics of 2 large groups and 3 subgroups to be analyzed. Results. L group patients had significantly more stage N2 axillary lymph nodes than H group patients (31.8% vs. 9.2%, <math xmlns=http://www.w3.org/1998/Math/MathML id=M1> <mi>P</mi> </math> = 0.007). Age ( <math xmlns=http://www.w3.org/1998/Math/MathML id=M2> <mi>P</mi> </math> = 0.011), menopause status ( <math xmlns=http://www.w3.org/1998/Math/MathML id=M3> <mi>P</mi> </math> = 0.001), and tumor size ( <math xmlns=http://www.w3.org/1998/Math/MathML id=M4> <mi>P</mi> </math> = 0.024) were significantly different in the HL vs. HH and LL groups. Five-year DFS (94.6% vs. 77.0%, <math xmlns=http://www.w3.org/1998/Math/MathML id=M5> <mi>P</mi> </math> < 0.001) and 5-year OS (97.2% vs. 85.8%, <math xmlns=http://www.w3.org/1998/Math/MathML id=M6> <mi>P</mi> </math> = 0.001) rates significantly differed between HH and HL. No significant differences in 5-year DFS (77.0% vs. 81.9%, <math xmlns=http://www.w3.org/1998/Math/MathML id=M7> <mi>P</mi> </math> = 0.564) or 5-year OS (85.8% vs. 87.8%, <math xmlns=http://www.w3.org/1998/Math/MathML id=M8> <mi>P</mi> </math> = 0.729) rates were observed between HL and LL; the OS rates of HL and LL were similar. Conclusion. In the group of ER+/PR+/HER2-patients, there was no significant prognostic difference between ER-low positive and ER-high positive groups, but low PR expression was significantly associated with a worse prognosis. The role of ER and PR balance in breast cancer progression and individualized treatment requires further investigation." @default.
• W4310289576 created "2022-11-30" @default.
• W4310289576 creator A5022380264 @default.
• W4310289576 creator A5026182969 @default.
• W4310289576 creator A5036246267 @default.
• W4310289576 creator A5043774346 @default.
• W4310289576 creator A5048703302 @default.
• W4310289576 creator A5050020268 @default.
• W4310289576 creator A5069744947 @default.
• W4310289576 creator A5076305035 @default.
• W4310289576 date "2022-11-29" @default.
• W4310289576 modified "2023-09-26" @default.
• W4310289576 title "Clinical Features and Prognosis Analysis of Hormone Receptor-Positive, HER2-Negative Breast Cancer with Differential Expression Levels of Estrogen and Progesterone Receptors: A 10-Year Retrospective Study" @default.
• W4310289576 cites W1531348775 @default.
• W4310289576 cites W1892496998 @default.
• W4310289576 cites W2010714248 @default.
• W4310289576 cites W2012870865 @default.
• W4310289576 cites W2044702943 @default.
• W4310289576 cites W2062071674 @default.
• W4310289576 cites W2063874882 @default.
• W4310289576 cites W2073927677 @default.
• W4310289576 cites W2077560541 @default.
• W4310289576 cites W2094966013 @default.
• W4310289576 cites W2096864872 @default.
• W4310289576 cites W2097255042 @default.
• W4310289576 cites W2118728607 @default.
• W4310289576 cites W2123179063 @default.
• W4310289576 cites W2125702566 @default.
• W4310289576 cites W2128347157 @default.
• W4310289576 cites W2131308508 @default.
• W4310289576 cites W2140254592 @default.
• W4310289576 cites W2149495821 @default.
• W4310289576 cites W2154591735 @default.
• W4310289576 cites W2165104644 @default.
• W4310289576 cites W2165432902 @default.
• W4310289576 cites W2259802687 @default.
• W4310289576 cites W2329942918 @default.
• W4310289576 cites W2607435391 @default.
• W4310289576 cites W2656233392 @default.
• W4310289576 cites W2748007439 @default.
• W4310289576 cites W2803725301 @default.
• W4310289576 cites W2888876774 @default.
• W4310289576 cites W2914589487 @default.
• W4310289576 cites W2954056327 @default.
• W4310289576 cites W2999400187 @default.
• W4310289576 cites W2999417355 @default.
• W4310289576 cites W3095101294 @default.
• W4310289576 doi "https://doi.org/10.1155/2022/5469163" @default.
• W4310289576 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36531979" @default.
• W4310289576 hasPublicationYear "2022" @default.
• W4310289576 type Work @default.
• W4310289576 citedByCount "1" @default.
• W4310289576 countsByYear W43102895762023 @default.
• W4310289576 crossrefType "journal-article" @default.
• W4310289576 hasAuthorship W4310289576A5022380264 @default.
• W4310289576 hasAuthorship W4310289576A5026182969 @default.
• W4310289576 hasAuthorship W4310289576A5036246267 @default.
• W4310289576 hasAuthorship W4310289576A5043774346 @default.
• W4310289576 hasAuthorship W4310289576A5048703302 @default.
• W4310289576 hasAuthorship W4310289576A5050020268 @default.
• W4310289576 hasAuthorship W4310289576A5069744947 @default.
• W4310289576 hasAuthorship W4310289576A5076305035 @default.
• W4310289576 hasBestOaLocation W43102895761 @default.
• W4310289576 hasConcept C121608353 @default.
• W4310289576 hasConcept C126322002 @default.
• W4310289576 hasConcept C143998085 @default.
• W4310289576 hasConcept C2777164284 @default.
• W4310289576 hasConcept C2777649267 @default.
• W4310289576 hasConcept C29456083 @default.
• W4310289576 hasConcept C530470458 @default.
• W4310289576 hasConcept C71924100 @default.
• W4310289576 hasConcept C84606932 @default.
• W4310289576 hasConcept C98717036 @default.
• W4310289576 hasConceptScore W4310289576C121608353 @default.
• W4310289576 hasConceptScore W4310289576C126322002 @default.
• W4310289576 hasConceptScore W4310289576C143998085 @default.
• W4310289576 hasConceptScore W4310289576C2777164284 @default.
• W4310289576 hasConceptScore W4310289576C2777649267 @default.
• W4310289576 hasConceptScore W4310289576C29456083 @default.
• W4310289576 hasConceptScore W4310289576C530470458 @default.
• W4310289576 hasConceptScore W4310289576C71924100 @default.
• W4310289576 hasConceptScore W4310289576C84606932 @default.
• W4310289576 hasConceptScore W4310289576C98717036 @default.
• W4310289576 hasFunder F4320322595 @default.
• W4310289576 hasLocation W43102895761 @default.
• W4310289576 hasLocation W43102895762 @default.
• W4310289576 hasLocation W43102895763 @default.
• W4310289576 hasLocation W43102895764 @default.
• W4310289576 hasOpenAccess W4310289576 @default.
• W4310289576 hasPrimaryLocation W43102895761 @default.
• W4310289576 hasRelatedWork W176734082 @default.
• W4310289576 hasRelatedWork W2038599327 @default.
• W4310289576 hasRelatedWork W2093476509 @default.
• W4310289576 hasRelatedWork W2101821182 @default.
• W4310289576 hasRelatedWork W2150216118 @default.
• W4310289576 hasRelatedWork W2357456301 @default.
• W4310289576 hasRelatedWork W2365274008 @default.
• W4310289576 hasRelatedWork W2953241133 @default.

• next